Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John Headlam
Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Related publications
Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Gastroenterology
Hepatology
Gastroenterology
Self-Fulfilling Prophecy
Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab
Gastroenterologie a Hepatologie
Hepatology
Gastroenterology
OC16.06: Macrosomia: A Self-Fulfilling Prophecy
Ultrasound in Obstetrics and Gynecology
Nuclear Medicine
Radiology
Ultrasound Technology
Gynecology
Reproductive Medicine
Radiological
Imaging
Obstetrics
Medicine
Editorial: Infliximab De-Escalation in Inflammatory Bowel Disease Using a Therapeutic Drug Monitoring Strategy - Early Promise but More Data Needed. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Renal Tubular Dysfunction in Patients With Inflammatory Bowel Disease Treated With Aminosalicylate.
Gut
Gastroenterology
Suppression of Anti-Drug Antibodies to Infliximab or Adalimumab With the Addition of an Immunomodulator in Patients With Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Therapeutic Drug Monitoring and Inflammatory Bowel Disease-A Call for an Urgent Standardization of the Results
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
